Study ID: C38072/3084
Study Title
- Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Teva Identifier
- C38072/3084
ClinicalTrials.gov Identifier
- NCT01508936
Study Status
- Completed
Trial Condition(s)
- Eosinophilic Asthma
Interventions
- Drug: Reslizumab | Drug: Placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 65 Years
Trial Duration
- 02/01/2012 - 08/01/2013
Phase
- Phase 3
Study Type
Interventional
